WHO South-East Asia Journal of Public Health
  • 939
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
POLICY AND PRACTICE
Year : 2021  |  Volume : 10  |  Issue : 3  |  Page : 49-58

Decentralization of India Hypertension Control Initiative services to maintain continuum of care for hypertensive patients during COVID-19 pandemic in Telangana


1 WHO India-supported India Hypertension Control Initiative, Telangana, India
2 WHO Country Office for India, New Delhi, India
3 Resolve to Save Lives, New Delhi, India
4 Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi, India
5 Indian Council of Medical Research, New Delhi, India
6 State Non-Communicable Disease Cell, Directorate of Health Services, Hyderabad, Telangana, India

Correspondence Address:
Dr Kiran Durgad
WHO India-supported India Hypertension Control Initiative, Telangana
India
Login to access the Email id


DOI: 10.4103/2224-3151.309873

Rights and Permissions

The India Hypertension Control Initiative (IHCI) was launched in Telangana, India, with the vision of maintaining the continuum of care for hypertensive patients and improving treatment outcomes through provision of free hypertension medication. Decentralization of the IHCI towards more patient-centred services was undertaken to bring free medication and follow-up services closer to the community in the hopes of improving follow-up and control rates for hypertensive patients. To determine if decentralization of hypertension follow-up services and free medication to peripheral health centres improved continuity of care and treatment outcomes in hypertensive patients and helped to mitigate disruption during the coronavirus disease 2019 (COVID-19) pandemic, hypertension outcomes were reviewed before and during the COVID-19 pandemic, for patients registered in health centres that decentralized free medication and follow-up services to subcentres – the intervention group – and in health centres that did not decentralize these services – the non-intervention group. Hypertensive patients had higher rates of monthly follow-up and controlled blood pressure in the decentralized facilities than in the non-decentralized facilities, where these services were limited to primary and secondary health centres. Comparing follow-up rates and blood pressure control rates before and during the COVID-19 pandemic, these were maintained for patients in the decentralized facilities whereas they were significantly lower for patients in the non-decentralized facilities. The IHCI decentralized model appears to have contributed to continuity of care for people with hypertension and to have maintained this continuity against system shocks such as that of the COVID-19 pandemic. Decentralization of free medicines and follow-up services to the first and most peripheral point of contact in the primary health care system brings these essential services closer to home, which can encourage patients to seek services from the public sector – capturing a strong case for a primary health care foundation to the strengthening of systems for universal health coverage.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2467    
    Printed108    
    Emailed0    
    PDF Downloaded244    
    Comments [Add]    
    Cited by others 3    

Recommend this journal